Abstract Glucagon-like peptide-1 receptor agonists (GLP-1RAs) are revolutionizing the management of metabolic and liver diseases, demonstrating effectiveness in controlling blood sugar levels and promoting liver repair
At the end of the study, the authors observed improved dermal density, reduced periorbital wrinkles, and skin smoothness in the treatment group
We need better evidence on how these medications work and what to do after stopping, such as how to transition care and what kinds of lifestyle and psychological support help to maintain benefits. The new research comes at a time when access to, and interest in, weight-loss medications is rapidly expanding across the globe
This is a primary antioxidant enzyme that helps protect body cells from oxidative damage
It boosts metabolism by helping the liver detoxify and metabolize fats, and reducing oxidative stress, which further improves insulin sensitivity and aids in weight management
These interactions may result in low blood sugar levels, severe dizziness, or fainting episodes